company background image
AEMD

Aethlon Medical NasdaqCM:AEMD Stock Report

Last Price

US$1.27

Market Cap

US$29.1m

7D

-3.1%

1Y

-64.3%

Updated

16 Aug, 2022

Data

Company Financials +
AEMD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

AEMD Stock Overview

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.

Aethlon Medical Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aethlon Medical
Historical stock prices
Current Share PriceUS$1.27
52 Week HighUS$5.99
52 Week LowUS$0.88
Beta0.78
1 Month Change20.95%
3 Month Change18.69%
1 Year Change-64.33%
3 Year Change-67.41%
5 Year Change-94.04%
Change since IPO-99.98%

Recent News & Updates

Aug 02
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Shareholder Returns

AEMDUS Medical EquipmentUS Market
7D-3.1%3.6%4.5%
1Y-64.3%-20.7%-8.9%

Return vs Industry: AEMD underperformed the US Medical Equipment industry which returned -19.6% over the past year.

Return vs Market: AEMD underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is AEMD's price volatile compared to industry and market?
AEMD volatility
AEMD Average Weekly Movement24.2%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.6%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: AEMD is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 24% a week.

Volatility Over Time: AEMD's weekly volatility has increased from 15% to 24% over the past year.

About the Company

FoundedEmployeesCEOWebsite
199914Chuck Fisherhttps://www.aethlonmedical.com

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer.

Aethlon Medical Fundamentals Summary

How do Aethlon Medical's earnings and revenue compare to its market cap?
AEMD fundamental statistics
Market CapUS$29.08m
Earnings (TTM)-US$11.22m
Revenue (TTM)US$162.20k

179.4x

P/S Ratio

-2.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AEMD income statement (TTM)
RevenueUS$162.20k
Cost of RevenueUS$0
Gross ProfitUS$162.20k
Other ExpensesUS$11.39m
Earnings-US$11.22m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.49
Gross Margin100.00%
Net Profit Margin-6,920.18%
Debt/Equity Ratio0%

How did AEMD perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is AEMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AEMD?

Other financial metrics that can be useful for relative valuation.

AEMD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue90.8x
Enterprise Value/EBITDA-1.3x
PEG Ration/a

Price to Book Ratio vs Peers

How does AEMD's PB Ratio compare to its peers?

AEMD PB Ratio vs Peers
The above table shows the PB ratio for AEMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average2.9x
RMSL REMSleep Holdings
7.8xn/aUS$28.8m
VERO Venus Concept
1.3x74.3%US$29.5m
BIOL BIOLASE
1.6x23.7%US$34.2m
EKSO Ekso Bionics Holdings
1x64.7%US$31.2m
AEMD Aethlon Medical
1.9x-27.9%US$29.1m

Price-To-Book vs Peers: AEMD is good value based on its Price-To-Book Ratio (1.9x) compared to the peer average (2.9x).


Price to Earnings Ratio vs Industry

How does AEMD's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Book vs Industry: AEMD is good value based on its Price-To-Book Ratio (1.9x) compared to the US Medical Equipment industry average (2.9x)


Price to Book Ratio vs Fair Ratio

What is AEMD's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AEMD PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio1.9x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate AEMD's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of AEMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AEMD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AEMD's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is Aethlon Medical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-27.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AEMD's earnings are forecast to decline over the next 3 years (-27.9% per year).

Earnings vs Market: AEMD is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: AEMD is expected to become profitable in the next 3 years.

Revenue vs Market: AEMD's revenue is expected to decline over the next 3 years (-24.6% per year).

High Growth Revenue: AEMD's revenue is forecast to decline over the next 3 years (-24.6% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AEMD's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Aethlon Medical performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-12.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AEMD is currently unprofitable.

Growing Profit Margin: AEMD is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AEMD is unprofitable, and losses have increased over the past 5 years at a rate of 12% per year.

Accelerating Growth: Unable to compare AEMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AEMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.5%).


Return on Equity

High ROE: AEMD has a negative Return on Equity (-75.26%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Aethlon Medical's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: AEMD's short term assets ($15.9M) exceed its short term liabilities ($1.6M).

Long Term Liabilities: AEMD's short term assets ($15.9M) exceed its long term liabilities ($567.3K).


Debt to Equity History and Analysis

Debt Level: AEMD is debt free.

Reducing Debt: AEMD currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AEMD has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: AEMD has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 18.7% each year.


Discover healthy companies

Dividend

What is Aethlon Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate AEMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AEMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AEMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AEMD's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AEMD has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average management tenure


CEO

Chuck Fisher (75 yo)

1.83yrs

Tenure

US$2,477,896

Compensation

Dr. Charles J. Fisher, Jr., also known as Chuck, M.D. has been Chief Executive Officer of Aethlon Medical, Inc. since October 30, 2020. He serves as the Chief Executive Officer of Margaux Biologics, Inc. s...


CEO Compensation Analysis

Compensation vs Market: Chuck's total compensation ($USD2.48M) is above average for companies of similar size in the US market ($USD759.98K).

Compensation vs Earnings: Chuck's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: AEMD's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

Experienced Board: AEMD's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 48.8%.


Top Shareholders

Company Information

Aethlon Medical, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Aethlon Medical, Inc.
  • Ticker: AEMD
  • Exchange: NasdaqCM
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$29.083m
  • Shares outstanding: 22.90m
  • Website: https://www.aethlonmedical.com

Number of Employees


Location

  • Aethlon Medical, Inc.
  • 11555 Sorrento Valley Road
  • Suite 203
  • San Diego
  • California
  • 92121
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/16 00:00
End of Day Share Price2022/08/16 00:00
Earnings2022/06/30
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.